John C.S. Breitner

Joint

1971 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John C.S. Breitner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Alzheimer Disease Medicine & Life Sciences
Dementia Medicine & Life Sciences
Anti-Inflammatory Agents Medicine & Life Sciences
Cognition Medicine & Life Sciences
Apolipoproteins E Medicine & Life Sciences
Alleles Medicine & Life Sciences
Vascular Dementia Medicine & Life Sciences
Population Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1971 2019

A highly predictive signature of cognition and brain atrophy for progression to Alzheimer's dementia

Alzheimer's Disease Neuroimaging Initiative, May 1 2019, In : GigaScience. 8, 5

Research output: Contribution to journalArticle

Open Access
Cognition
Atrophy
Learning systems
Brain
Alzheimer Disease

Association of PPP2R1A with Alzheimer's disease and specific cognitive domains

United Kingdom Brain Expression Consortium & PREVENT-AD Research Group, Sep 1 2019, In : Neurobiology of Aging. 81, p. 234-243 10 p.

Research output: Contribution to journalArticle

Alzheimer Disease
Population
Brain
Chromosomes, Human, Pair 19
Intergenic DNA

Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation

PREVENT-AD Research Group, Jan 1 2019, In : Alzheimer's and Dementia.

Research output: Contribution to journalArticle

Alzheimer Disease
Biomarkers
Inflammation
Interleukin-1
Population

Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression

Liebsch, F., Kulic, L., Teunissen, C., Shobo, A., Ulku, I., Engelschalt, V., Hancock, M. A., van der Flier, W. M., Kunach, P., Rosa-Neto, P., Scheltens, P., Poirier, J., Saftig, P., Bateman, R. J., Breitner, J. C. S., Hock, C. & Multhaup, G., Dec 1 2019, In : Nature communications. 10, 1, 2240.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal fluid
Amyloid beta-Protein Precursor
clearances
Amyloid
progressions

Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology

Meyer, P. F., Savard, M., Poirier, J., Morgan, D. & Breitner, J. C. S., Jan 1 2019, (Accepted/In press) In : Alzheimer's and Dementia.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal Fluid Proteins
Alzheimer Disease
Pathology
Biomarkers
Neuroimaging